Mid-dermal elastolysis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:228299L98.8
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mid-dermal elastolysis (MDE) is a rare acquired disorder of elastic tissue characterized by the selective loss of elastic fibers in the mid-dermis (the middle layer of the skin's connective tissue). The condition predominantly affects young to middle-aged women, though cases in men have been reported. It presents clinically with areas of fine wrinkling or perifollicular papular protrusions on the trunk, upper arms, neck, and occasionally other body areas. The skin in affected regions appears thin, lax, and finely wrinkled, giving a prematurely aged appearance. Two main clinical patterns have been described: a diffuse fine wrinkling type and a perifollicular papular type. The condition is generally limited to the skin and does not involve internal organs. The exact cause of mid-dermal elastolysis remains unknown. It has been associated with sun exposure, and some cases have been linked to inflammatory processes or autoimmune conditions, though no consistent underlying etiology has been established. Histologically, the hallmark finding is a band-like loss of elastic fibers in the mid-dermis, with preservation of elastic fibers in the superficial (papillary) and deep (reticular) dermis. There may be a mild perivascular inflammatory infiltrate. The condition is distinct from other elastolytic disorders such as anetoderma, cutis laxa, and granulomatous slack skin. Currently, there is no established curative treatment for mid-dermal elastolysis. The condition is generally considered benign and primarily of cosmetic concern, though it can be psychologically distressing for affected individuals. Various treatments have been attempted with limited success, including topical retinoids, sun protection, and anti-inflammatory agents. Some reports have described partial improvement with dapsone or colchicine in cases with an inflammatory component. Sun avoidance and photoprotection are generally recommended. The prognosis is favorable in terms of overall health, but the skin changes tend to be progressive and persistent.

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mid-dermal elastolysis.

View clinical trials →

No actively recruiting trials found for Mid-dermal elastolysis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mid-dermal elastolysis community →

Specialists

15 foundView all specialists →
LZ
Li-Hua Zhang
Specialist
1 Mid-dermal elastolysis publication
YL
Yan-Ling Li
Specialist
1 Mid-dermal elastolysis publication
TG
Thilo Gambichler
Specialist
1 Mid-dermal elastolysis publication
FO
Frank Oellig
Specialist
1 Mid-dermal elastolysis publication
SI
Sevda Inalkac
Specialist
1 Mid-dermal elastolysis publication
LS
Laura Susok
Specialist
1 Mid-dermal elastolysis publication
SB
Stefanie Boms
Specialist
1 Mid-dermal elastolysis publication
SA
Sabita Aryal
Specialist
1 Mid-dermal elastolysis publication
YL
Yaoyu Li
Specialist
1 Mid-dermal elastolysis publication
SB
Subodh Bashyal
Specialist
1 Mid-dermal elastolysis publication
LQ
Liu Ye Qiang
Specialist
1 Mid-dermal elastolysis publication
DV
Deepak Vashisht
Specialist
1 Mid-dermal elastolysis publication
PS
Preema Sinha
Specialist
1 Mid-dermal elastolysis publication
MM
Manoj G Madakshira
Specialist
1 Mid-dermal elastolysis publication
AR
Abdur Rehman
DANVILLE, PA
Specialist
1 Mid-dermal elastolysis publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mid-dermal elastolysis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mid-dermal elastolysisForum →

No community posts yet. Be the first to share your experience with Mid-dermal elastolysis.

Start the conversation →

Latest news about Mid-dermal elastolysis

No recent news articles for Mid-dermal elastolysis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mid-dermal elastolysis

What is Mid-dermal elastolysis?

Mid-dermal elastolysis (MDE) is a rare acquired disorder of elastic tissue characterized by the selective loss of elastic fibers in the mid-dermis (the middle layer of the skin's connective tissue). The condition predominantly affects young to middle-aged women, though cases in men have been reported. It presents clinically with areas of fine wrinkling or perifollicular papular protrusions on the trunk, upper arms, neck, and occasionally other body areas. The skin in affected regions appears thin, lax, and finely wrinkled, giving a prematurely aged appearance. Two main clinical patterns have b

How is Mid-dermal elastolysis inherited?

Mid-dermal elastolysis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mid-dermal elastolysis typically begin?

Typical onset of Mid-dermal elastolysis is adult. Age of onset can vary across affected individuals.

Which specialists treat Mid-dermal elastolysis?

15 specialists and care centers treating Mid-dermal elastolysis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.